Google Search

Search

Already a Member ?

Pharmaceutical, Drugs, Fine Chemicals, Bulk Drug Intermediates, Pharmaceutical Drugs, Pharma Drug Ingredients Intermediates, Drug Intermediates, Speciality Chemicals, Raw Materials, Fine and Specialty Chemicals Intermediates, Pharmaceutical Bulk Drugs

Indian drugs and pharmaceutical industry has advanced perceptibly and is getting ready  for the new patent regime and  to withstand global competition, which is expected to be unleashed by new winds of liberalisation - a new era of liberalisation - much different from what was ushered in since the conclusion of the Uruguay Round and the establishment of the World Trade Organisation.

The industry has been expanding at annual rates ranging between 8 to 10% (against global growth rate of 6%).  According to a study  by McKinsey, Vision 2010, the domestic pharmaceutical industry could attain a size of  $25 billion (Rs 1200 billion) by 2010 by focusing on two areas: first, innovation-led research, development and new drug discoveries; and second, information technology-led remote sales and marketing.  The market for bulk drugs and formulations had increased from about Rs 103  billion in 1990-91 to an estimated Rs 435  billion at the end of 2003-04.  The prices of Indian essential drugs are among the lowest in the world. Apart from strides made by the industry in the last half-a-century, lower production cost due to reverse engineering and low R&D outlays has been a major factor in keeping the prices under check.

The global pharmaceutical industry is estimated at $ 300 billion, not all representing cross-border trade.  India's measly share of $ 1.5 billion in global trade represents an untapped potential. Under the regime of economic liberalisation underway since early 1990s, the drugs and pharmaceutical sector witnessed initiatives at fresh investment in the sector. Nearly 1735 investment proposals of the order of around Rs 166  billion were initiated. The foreign collaboration proposals approved numbered around 425 with a foreign direct investment  (FDI) component of over Rs 25 billion. The pharmaceuticals have figured high on the export front. In 2001-02,  the sector was  estimated to have registered a growth of 17.6% at around Rs 20.3 billion.

In the wake of economic liberalisation, many a  overseas players  returned or contemplated returning to India. These include Ivox Corp (USA),  Taro Pharmaceuticals (Israel) and Merck (USA). These are out either to set shop or looking for acquisitions in India. Hexal AG of Germany has established a liaison office in India. MILLIONCs like Rocha, Bayer, Aventis and Chiron are making India a regional hub for bulk drugs. 

The Export Import Bank of India (Exim Bank) had  doubled its corpus for the pharmaceutical industry to Rs 2 billion as a result of increased activity in the industry, especially in the external sector. The fund is used for the development and commercialisation of the new products and applications, significant improvement in the existing design of  products, setting up and expansion of pilot plants, research studies for obtaining regulatory approvals, cost of filing and managing international patent and R&D Centres.

It needs, however, to be recognised that the presence  of small scale manufacturers has resulted, on the one hand,  in a highly fragmented industry, and on the other, it has made it possible to supply a near 100,000 drugs including vitamins, antibiotics, antibacterials, cardio-vascular and other essential drugs. These account for nearly 37% of the market.  While each of about 80% of the manufacturers has annual sales below a billion rupees, top ten companies are known to control over 30% of the market. At present there are more than 20,000 players in the country.

The major players are: Alembic Chem, Aurobindo Pharma, Cipla, Dr. Reddy's, FDC, IPCA Labs, Jagsonpal Pharma, J.B. Chemicals, Kopran, Lupin Labs, Lyka Labs, Morepan Labs, Nicholas Piramal, Ranbaxy Labs, Sun Pharma, Themis Medicare, GlaxoSmithkline, Astrazeneca, Aventis, E-Merck, Torrent Pharma, TTK Healthcare, Unichem Labs,  Wockhardt  and  Zandu Pharma.  Until recently, only a few of the Indian companies had gone into any serious R&D activity. Much of the effort was directed to affordable analogue research. The R&D level in the country is low with even well-placed pharma companies spending less than 2% of turnover on R&D. MILLIONCs are known to contribute as much as 10% or more of their turnover to R&D.  While India is very strong in process chemistry, biology and applied bio-chemistry, initiatives at all levels - government, academia, private sector - involving heavy financial outlays, are called for.

Ayurveda continues to remain a preferred system of medicine for a vast segment of population in the country. The country has over 400,000 registered practitioners of the Indian system of medicine. Around 170 institutes properly affiliated to various universities impart under- or post-graduate courses each year. These institutes churn out some 5,500 fresh practitioners. The practitioners are supported by 12,000 dispensaries and 2,100 beds available for ayurveda treatment countrywide. The emerging biotechnology sector has already taken by storm and is offering sops to states to make these as the thriving ground for the highly potential segment in medicare.

How to Prepare Project Report on Pharmaceutical Processing Industry?

Drug manufacturing companies work under strict laws and regulations. Their processes need to comply with relevant drugs act in their respective countries.

Therefore, if you are planning to invest in pharmaceutical processing, a good project report will be necessary. Besides the prominent aspects of a project report, you should pay close attention to the following issues in a pharmaceutical processing report.

1. Marketing

This industry is very competitive. I need not stress the value of detailed market analysis. You need to understand the status of market competition and the demand for pharmaceutical products. A proper market analysis will additionally help you prepare an excellent pharmaceutical business plan. Given your market analysis report, you will develop a marketing plan.

2. Government approval

In almost all countries, there are laws and regulations for the manufacture, distribution, and administration of drugs. Consider giving a status report on these requirements when making the final project status report.

3. Manufacturing Process

It would help if you had a picture of the process you will employ in making your drugs. Outline the quality checks and balances in the process. State the required pharmaceutical intermediates and their corresponding active pharmaceutical ingredients.

4. Machines and Equipment

You need to identify the equipment you will need, such as homogenizers, spectrophotometer, tabulating machines, etc. to ensure the machines meet quality specifications. You may also need to put down a plan to train workers on their operations.

How Does the Drug Manufacturing Process Work?

If you are an aspiring drug manufacturer, you should know how the bulk drug manufacturing process works. This is a complicated process and requires professional skills in molecular biology, medical microbiology, and pharmacy.

The process involves four steps, namely:

  • Milling
  • Granulation
  • Coating
  • Tabulation

Milling is important because it makes the drug powder uniform. It ensures uniform distribution of the active pharmaceutical ingredients. Additionally, milling makes it easier to formulate the drug into a syrup or emulsion.

After milling, you can use wet or dry granulation to form granules. You then coat them and compress the drugs using a tabulating machine. Alternatively, you can fill the granules into capsules.

For any chemical industry business ideas, prioritize the security of your staff. Ensure workers have sufficient PPEs. Have plans to protect them from chemical poisoning. Install eyewashes and emergency showers in both production units and laboratories.

Pre-Feasibility Report on Bulk Drug Manufacturing Process

Before you set up a feasibility report or start making a business plan, you first need to do a pre-feasibility study. It is the conclusions of this study that will make you decide whether to proceed to the project feasibility report or not.

Implementing a pharmacy business plan is an expensive affair. Please do not put any investment into a business plan of this magnitude without looking at its feasibility study report.

Considering the variety of pharmaceutical products, a feasibility plan will help you decide on the most relevant product for your target market. The results of pre-feasibility and feasibility studies will inform your marketing strategy plan. At the pre-feasibility stage, you get to review the technical skills required for the bulk drug manufacturing process. You also assess the knowledge level and determine whether you have the knowledge and skills.

Lastly, this report looks at the financial demands of a chemical project report on bulk drug processing. From here, you will decide on the feasibility of the project.

How to Grow Pharmaceutical Intermediates Market?

The pharmaceutical industry relies on pharmaceutical intermediates. We use these chemicals to produce active pharmaceutical ingredients (API). 

To grow the pharmaceutical intermediates market, therefore, we should focus on the drug manufacturing industry. Here are some tips on how we can grow this industry.

1. Investment in Research and Development

We should encourage governments and established drug manufacturers to invest in research and development of new medicines. New drug development will increase the need for pharmaceutical intermediates. Consequently, this will cause the growth of the industry.

2. Boost Generic Drug Manufacturing

Feasibility study reports for project ideas in pharmaceuticals show a growing demand for generics. This demand is particularly high in developing countries. More investment in generic drugs will result in increased demand for pharmaceutical intermediates.

3. Collaborations

It is quite expensive to run a pharmaceutical intermediate processing company. If you look at a project summary example for the local industry and you will notice the huge investment. One way of cushioning the industry is to encourage collaborations, mergers, and acquisitions. Working together gives small-scale companies a competitive advantage. It lowers their operation costs and improves revenue.

How to Set Up a Chemical Industry Business Plan?

Writing a chemical industry business plan begins with a pre-feasibility study. Here, you look at the various business ideas in chemical manufacturing. You then evaluate each of these ideas based on:

1. Skills and Knowledge

If you are interested in the chemical manufacturing industry, I assume that you have some skills or knowledge in this sector. If so, look at the skills required for each idea you have. Which of these ideas marches your skills and knowledge?

2. Financial Resources

Different chemical processes have different cost implications. Try to review each idea against the expected financial input. You can examine some business plan examples on the internet to get a hint on required inputs. Once you have a convincing pre-feasibility report, you can proceed to make a feasibility report meaning the idea is profitable and viable.

The next step in setting up a chemical industry business plan is to prepare a small business marketing plan. The results of your feasibility report will help do this.

Chemical manufacturing is not only expensive, but it is also strictly regulated by law. It would be best if you had an innovative marketing strategy to break even. It would be best if you did an accurate market analysis.

A project report on the pharmaceutical industry helps you assess the dynamics of the industry. You will want to know who the major chemical manufacturers are. You will also assess the availability of raw materials and machinery for your pharmaceutical industry.

In your project report, you will also address the technical aspects of the pharmaceutical manufacturing process. You need to draw a flow diagram for the process. Lastly, sit down and draw a business plan for your chemical industry business. You will need the information from all the above processes. Additionally, a business plan will consider the financial implications of your pharmaceutical industry project report.


We can provide you detailed project reports on the following topics. Please select the projects of your interests.

Each detailed project reports cover all the aspects of business, from analysing the market, confirming availability of various necessities such as plant & machinery, raw materials to forecasting the financial requirements. The scope of the report includes assessing market potential, negotiating with collaborators, investment decision making, corporate diversification planning etc. in a very planned manner by formulating detailed manufacturing techniques and forecasting financial aspects by estimating the cost of raw material, formulating the cash flow statement, projecting the balance sheet etc.

We also offer self-contained Pre-Investment and Pre-Feasibility Studies, Market Surveys and Studies, Preparation of Techno-Economic Feasibility Reports, Identification and Selection of Plant and Machinery, Manufacturing Process and or Equipment required, General Guidance, Technical and Commercial Counseling for setting up new industrial projects on the following topics.

Many of the engineers, project consultant & industrial consultancy firms in India and worldwide use our project reports as one of the input in doing their analysis.

We can modify the project capacity and project cost as per your requirement.
We can also prepare project report on any subject as per your requirement.

Page 12 of 21 | Total 203 projects in this category
« Previous   Page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 .... 20 21   Next »

Add multiple items to inquiry
Select the items and then press Add to inquiry button

Select all | Clear all Sort by

PHARMACEUTICAL UNIT (Automatic Plant of Tablet and Capsule) - Manufacturing Plant, Detailed Project Report, Profile, Business Plan, Industry Trends, Market Research, Survey, Manufacturing Process, Machinery, Raw Materials, Feasibility Study

The Indian pharmaceutical sector has come a long way, being almost non-existent before 1970 to a prominent provider of healthcare products, meeting almost 95 per cent of the country's pharmaceuticals needs. The Industry today is in the front rank of India’s science-based industries with wide ranging capabilities in the complex field of drug manufacture and technology. It ranks very high in the third world, in terms of technology, quality and range of medicines manufactured. From simple headache pills to sophisticated antibiotics and complex cardiac compounds, almost every type of medicine is now made indigenously. Indian Pharma Industry is playing a key role in promoting and sustaining development in the vital field of medicines, besides this it boasts of quality producers and many units approved by regulatory authorities in USA and UK. International companies associated with this sector have stimulated, assisted and spearheaded this dynamic development in the past 53 years and helped to put India on the pharmaceutical map of the world. The Indian Pharmaceutical sector is highly fragmented with more than 20,000 registered units. It has expanded drastically in the last two decades. The leading 250 pharmaceutical companies control 70% of the market, with market leader holding nearly 7% of the market share. It is an extremely fragmented market with severe price competition and government price control. The pharmaceutical industry in India meets around 70% of the country's demand for bulk drugs, drug intermediates, pharmaceutical formulations, chemicals, tablets, capsules, orals and injectables. There are about 250 large units and about 8000 Small Scale Units, which form the core of the pharmaceutical industry in India (including 5 Central Public Sector Units). These units produce the complete range of pharmaceutical formulations, i.e., medicines ready for consumption by patients and about 350 bulk drugs, i.e., chemicals having therapeutic value and used for production of pharmaceutical formulations. Technologically strong and totally self-reliant, the pharmaceutical industry in India has low costs of production, low R&D costs, innovative scientific manpower, strength of national laboratories and an increasing balance of trade. The Pharmaceutical Industry, with its rich scientific talents and research capabilities, supported by Intellectual Property Protection regime is well set to take on the international market. Market Survey The Indian pharmaceutical industry is the fourth largest in the world in terms of volume of output and thirteenth in domestic demand. However, the Indian industry, valued at USD 17 bn in represented just over 1% of the global pharmaceutical industry in value terms. The domestic market is estimated at Rs 680 bn. According to a study by McKinsey, Vision 2010, the domestic pharmaceutical industry could attain a size of USD 25 bn (Rs 1200 bn) by 2010 by focusing on two areas: first, innovation-led research, development and new drug discoveries; and second, information technology-led remote sales and marketing. Incidentally, according to another report by Associated Chamber of Commerce (ASSOCHAM) in India, the market is estimated to grow to more modest level of USD 9.5 bn in 2010). India has the world's third largest active pharmaceutical ingredients (API) for the industry valued at a little less than USD 2 bn. Top 5 API producers account for approximately 6.5 %. The leading APIs are anti-infective, gastrointestinal, cardiovascular and respiratory drugs. However, India's pharmaceutical industry might witness some decline in the number of smaller companies that either leave the market or are acquired by larger Indian or foreign companies. Since 2000, a number of smaller Indian pharmaceutical companies have, in fact, been acquired by larger companies. These cases include, among the more notable ones, Wockhardt's acquisition of Merind and Tata Pharma; Ranbaxy's purchase of Crosland; Nicholas Piramal's acquisition of Roche etc. The Indian firms produce nearly 60,000 generic brands in 60 therapeutic categories and between 350 and 400 bulk drugs. India's drug market consists mainly of second and third generation drugs no longer subject to patent protection in the developed world. Although India is the world's leading producer of generic drugs, its annual per capita consumption of pharmaceuticals has been among the lowest placed approximately at USD 4.50 per person as compared to USD 820 in the United States and USD 13 in China. The bulk drugs segment continues to be the highest revenue generating segment for the Indian pharma industry. It accounts for production worth Rs 120 bn and contributes about 36% of the total pharma exports. India produces 400 bulk drugs through its 1,300 licensed bulk drug units that cater to most of the domestic bulk drug requirements. The key categories driving growth are the traditionally largest segment - anti-infective and gastro-intestinal, drugs, which expanded by 22% and 19% respectively. Fast sales growth is also visible in categories like respiratory (18%), cardiac (14%), neurology (20%) and anti-diabetic (19%). Anti-TB is the only category that has seen a decline in value and volume terms. The number of product launches exceeds 2,000 annually. Both MNC and Indian companies are implementing strategies which will help them to benefit from and cope with the developing patent regime. Global pharma companies are increasingly exploring low cost option to outsource research and manufacturing, because of emerging slow-down in patented drug sales and high cost of R&D. Indian pharmaceutical companies are in various stages of new drug discoveries. They have been scouting for global partners to help them in their goal. However, companies like Dr Reddy's Laboratories, Wockhardt’s, Glen mark Pharmaceuticals, Ranbaxy Laboratories, Orchid Chemicals and Lupin need financial and technical support from foreign pharmaceutical players to take their new drugs to the global market. Dr. Reddy's Laboratory (DRL) recently announced the beginning of Phase III clinical trials of its anti-diabetic drug Balagliatzone. Co-developed with Danish firm Rheoscience, the successful completion of the trial could give India its first intellectual property from the pharma sector. India has the highest number of (US Food and Drug Administration) USFDA approved manufacturing facilities outside the US and this puts India in good position to export to regulated markets. The major players in the country are: Aanjaneya Lifecare Ltd. Aashi Industries Ltd. Abbott India Ltd. Advik Laboratories Ltd. Aesculapius Remedies Ltd. Ajanta Pharma Ltd. Albert David Ltd. Alkem Laboratories Ltd. Alpa Laboratories Ltd. Ambalal Sarabhai Enterprises Ltd. Amee Cosmo Pharma Ltd. American Remedies Ltd. Amstrin Healthcare Ltd. Anan Drug & Chem Ltd. Andre Laboratories Ltd. Anglo-French Drugs & Inds. Ltd. Ankur Drugs & Pharma Ltd. Anmol Drugs & Pharmaceuticals Ltd. Anuh Pharma Ltd. Apex Laboratories Ltd. Apple Laboratories Ltd. Armour Chemicals Ltd. Arvind Remedies Ltd. Astrazeneca Pharma India Ltd. Astron Drugs & Inds. Ltd. Aurobindo Pharma Ltd. Aventis Pharma Ltd. B D H Industries Ltd. Bafna Pharmaceuticals Ltd. Bal Pharma Ltd. Basav Chem Ltd. Bassein Drugs Ltd. Beem Healthcare Ltd. Bengal Immunity Ltd. Beryl Drugs Ltd. Bharat Parenterals Ltd. Bharat Serums & Vaccines Ltd. Biddle Sawyer Ltd. Bio-Ethicals Pharma Ltd. Biocon Biopharmaceuticals Pvt. Ltd. Biocon Ltd. Biofil Chemicals & Pharmaceuticals Ltd. Biological E. Ltd. Blue Cross Laboratories Ltd. Boehringer Mannheim India Ltd. Brabourne Enterprises Ltd. Bravo Healthcare Ltd. Brawn Biotech Ltd. Burroughs Wellcome (India) Ltd. Cadila Healthcare Ltd. Cadila Laboratories Pvt. Ltd. Cadila Pharmaceuticals Ltd. Caplin Point Laboratories Ltd. Caryl Laboratories Ltd. Casil Industries Ltd. Celestial Biolabs Ltd. Centaur Pharmaceuticals Pvt. Ltd. Cepham Organics Ltd. Cepham Pharmaceuticals Ltd. Chemech Laboratories Ltd. Chemosyn Ltd. Ciba Ckd Biochem Ltd. Claris Lifesciences Ltd. Colinz Laboratories Ltd. Combat Drugs Ltd. Concept Pharmaceuticals Ltd. Concord Biotech Ltd. Concord Drugs Ltd. Coral Laboratories Ltd. Core Laboratories Ltd. Cosme Farma Laboratories Ltd. Cosme Pharma Ltd. Creative Health Care Pvt. Ltd. Croslands Research Laboratories Ltd. Croydon Chemical Works Ltd. Curewell (India) Ltd. Damania Pharma Ltd. Deepharma Laboratories Ltd. Deepharma Ltd. Dey'S Medical Stores Mfg. Ltd. Dishman Pharmaceuticals & Chemicals Ltd. Dolphin Laboratories Ltd. Dr. Reddy'S Laboratories Ltd. Druid Pharma Ltd. Dujohn Laboratories Ltd. Dumex Ltd. Eaco Labs Ltd. Earnest Healthcare Ltd. East India Pharmaceutical Works Ltd. Ebers Pharmaceuticals Ltd. Elder Health Care Ltd. Elder Pharmaceuticals Ltd. Elder Projects Ltd. Elvina Pharmaceuticals Ltd. Emaai Pharma Ltd. Emcure Pharmaceuticals Ltd. Endo Labs Ltd. Entod Pharmaceuticals Ltd. Esskay Pharmaceuticals Ltd. Ethnor Ltd. Eupharma Laboratories Ltd. Everest Organics Ltd. Evid & Co. Chemicals Ltd. F D C Ltd. Fine Drugs & Chemicals Ltd. Flamingo Pharmaceuticals Ltd. Fredun Pharmaceuticals Ltd. Fresenius Kabi Oncology Ltd. Fulford (India) Ltd. Geno Pharmaceuticals Ltd. Gentech Laboratories Ltd. Geoffrey Manners & Co. Ltd. German Remedies Ltd. Glaxosmithkline Pharmaceuticals Ltd. Glen mark Exports Ltd. Glen mark Generics Ltd. Glen mark Laboratories Ltd. Glen mark Pharmaceuticals Ltd. Global Remedies Ltd. Goa Antibiotics & Pharmaceuticals Ltd. Group Pharmaceuticals Ltd. Guardian Health Care Ltd. Gufic Biosciences Ltd. Gujarat Inject Ltd. Gujarat Terce Laboratories Ltd. Gujarat Themis Biosyn Ltd. H O D Laboratories Ltd. Hab Pharmaceuticals & Research Ltd. Haffkine Ajintha Pharmaceuticals Ltd. Hallmark Healthcare Ltd. Harleystreet Pharmaceuticals Ltd. Health Care Ltd. Hexone Pharmaceuticals Ltd. Hindustan Max-Gb Ltd. Hub Pharmaceuticals Pvt. Ltd. I D P L (Tamil Nadu) Ltd. Icon Biopharma & Healthcare Ltd. Icpa Health Products Ltd. Idma Laboratories Ltd. Ind-Swift Laboratories Ltd. Ind-Swift Ltd. India Infusion Ltd. Indian Drugs & Pharmaceuticals Ltd. Indoco Healthcare Ltd. Indoco Remedies Ltd. Indon Healthcare Ltd. Innotech Pharma Ltd. Intas Pharmaceuticals Ltd. Intercare Limited Intercare Ltd. International Drug Co. Ltd. Inventia Healthcare Pvt. Ltd. Inwinex Pharmaceuticals Ltd. Ipca Laboratories Ltd. Ivee Injectaa Ltd. J B Chemicals & Pharmaceuticals Ltd. J K Pharmachem Ltd. Jagsonpal Exports India Pvt. Ltd. Jagsonpal Pharmaceuticals Ltd. Jenburkt Pharmaceuticals Ltd. Jilichem Laboratories (India) Ltd. John Wyeth (India) Ltd. Johnson & Johnson Ltd. Kabra Drugs Ltd. Kappac Pharma Ltd. Karnataka Antibiotics & Pharmaceuticals Ltd. Kee Pharma Ltd. Kilitch Drugs (India) Ltd. Konkan Capsules Ltd. Krebs Biochemicals & Inds. Ltd. Labinduss Ltd. Lekar Healthcare Ltd. Lekar Pharma Ltd. Lincoln Pharmaceuticals Ltd. Liva Healthcare Ltd. Lordvin Labs Ltd. Lupin Laboratories Ltd. Lupin Ltd. Lyka B D R International Ltd. Lyka Labs Ltd. Lympha Laboratories Ltd. M J Pharmaceuticals Ltd. Macleods Pharmaceuticals Ltd. Maharashtra Antibiotics & Pharmaceuticals Ltd. Makers Laboratories Ltd. Maneesh Pharmaceuticals Ltd. Manipur State Drugs & Pharmaceuticals Ltd. Marck Biosciences Ltd. Mars Life Sciences Ltd. Martin & Harris Laboratories Ltd. Max India Ltd. Mayank & Lili Pharma Ltd. Mayo (India) Ltd. Mcneil & Argus Pharmaceuticals Ltd. Medicamen Biotech Ltd. Medispan Ltd. Medley Pharmaceuticals Ltd. Meghdoot Chemicals Ltd. Meher Pharma (India) Ltd. Merck Ltd. Mercury Laboratories Ltd. Mercury Phytochem Ltd. Merind Ltd. Mesco Pharmaceuticals Ltd. Metropolitan Overseas Ltd. Micro Labs Ltd. Monarch Laboratories Ltd. Morepen Laboratories Ltd. Mount Mettur Pharmaceuticals Ltd. N B Z Pharma Ltd. N R Jet Enterprises Ltd. Natco Pharma Ltd. Nem Organics Ltd. Neon Laboratories Ltd. Nestor Pharmaceuticals Ltd. Neulife Laboratories Ltd. Nirma Ltd. Nitya Laboratories Ltd. Novartis India Ltd. Novus Pharmaceuticals Ltd. Om Pharmaceuticals Ltd. Omega Biotech Ltd. Omega Laboratories Ltd. Onco Therapies Ltd. Opec Innovations Ltd. Orchid Chemicals & Pharmaceuticals Ltd. Organon (India) Ltd. Ozone Pharmaceuticals Ltd. P C I Chemicals & Pharmaceuticals Ltd. Paam Pharmaceuticals (Delhi) Ltd. Panacea Biotec Ltd. Parabolic Drugs Ltd. Paras Pharmaceuticals Ltd. Parke-Davis (India) Ltd. Penam Laboratories Ltd. Perk Pharmaceuticals Ltd. Pfimex Pharmaceuticals Ltd. Pfizer Ltd. Phaarmasia Ltd. Phar-East Laboratories Ltd. Pharmacia Healthcare Ltd. Pharmaids Pharmaceuticals Ltd. Pharmax Corporation Ltd. Pharmed Ltd. Phyto Specialities Pvt. Ltd. Plethico Pharmaceuticals Ltd. Procter & Gamble Hygiene & Health Care Ltd. Quality Pharmaceuticals Ltd. R P G Life Sciences Ltd. Rajasthan Drugs & Pharmaceuticals Ltd. Rajat Pharmachem Ltd. Ranbaxy Drugs Ltd. Ranbaxy Laboratories Ltd. Raptakos, Brett & Co. Ltd. Ravish Infusions Ltd. Reckitt Benckiser (India) Ltd. Rekvina Laboratories Ltd. Resonance Specialties Ltd. Rhone-Poulenc (India) Ltd. Rolex Pharmaceuticals Ltd. Rosemount Pharma India Ltd. Rubra Medicaments Ltd. Rupal Chemical Inds. Ltd. Rusan Pharma Ltd. S A M Biotech Ltd. Saket Projects Ltd. Sandoz (India) Ltd. [Amalgamated] Sanjeevanee Pharmaceuticals Ltd. Sanjivani Paranteral Ltd. Sanofi-Synthelabo (India) Ltd. Sarabhai Piramal Pharmaceuticals Pvt. Ltd. Sarala Pharmaceuticals Ltd. Sarthi Pharmaceuticals Ltd. Sarvodaya Labs Ltd. Schering-Plough (India) Pvt. Ltd. Senbo Industries Ltd. Shalina Laboratories Pvt. Ltd. Sharvani Pharmaceuticals Ltd. Shiv Herbal Research Laboratory Ltd. Sidmak Laboratories (India) Pvt. Ltd. Sigma Laboratories Ltd. Smith Stanistreet Pharmaceuticals Ltd. Smithkline Beecham Pharmaceuticals (India) Ltd. [Amalgamated] Solumiks Herbaceuticals Ltd. Sri Chakra Remedies Ltd. Sri Krishna Drugs Ltd. Sri Krishna Pharmaceuticals Ltd. Strides Arcolab Ltd. Sun Pharmaceutical Inds. Ltd. Surya Pharmaceutical Ltd. Sustime Pharma Ltd. Suyog Pharmaceuticals Pvt. Ltd. Swega Laboratories Ltd. Swet-Chem Antibiotics Ltd. Syncom Formulations (India) Ltd. Syncom Healthcare Ltd. T K Healthcare Ltd. Tablets (India) Ltd. Tamilnadu Dadha Pharmaceuticals Ltd. Targof Pure Drugs Ltd. Taulis Pharma Ltd. Teem Laboratories Ltd. Themis Medicare Ltd. Tonira Pharma Ltd. Torrent Pharmaceuticals Ltd. Toshvin Industries Ltd. Trans Medicare Ltd. Travel Co. In Pvt. Ltd. Troika Pharmaceuticals Ltd. Twilight Litaka Pharma Ltd. U S V Ltd. Uni-Sankyo Ltd. Uni-Ucb Ltd. Unibios Laboratories Ltd. Unichem Laboratories Ltd. Unicorn Pharmaceuticals (India) Ltd. Unimark Remedies Ltd. Unimed Investments Ltd. Unimed Technologies Ltd. Unique Pharmaceutical Laboratories Ltd. Universal Generics Ltd. Universal Pharmaceuticals Ltd. Unjha Formulations Ltd. Vellanova Pharmaceuticals Ltd. Venkat Pharma Ltd. Veronica Laboratories Ltd. Vista Pharmaceuticals Ltd. Vita Biopharma Pvt. Ltd. Vysali Pharmaceuticals Ltd. Wallace Pharmaceuticals Ltd. Wander Pvt. Ltd. Warren Pharmaceuticals Ltd. Welcure Drugs & Pharmaceuticals Ltd. White Way Products (Pharma) Ltd. Win-Medicare Pvt. Ltd. Wintac Ltd. Wockhardt’s Ltd. Wyeth Laboratories Ltd. Wyeth Ltd. Yogi Healthcare Ltd. Zenith Health Care Ltd. Zenotech Laboratories Ltd. Zillion Pharmachem Ltd. Zim Laboratories Ltd. Zuventus Healthcare Ltd. Zydus Animal Health Ltd. Zydus Pathline Ltd.
Plant capacity: 117 Lakhs Nos. /annumPlant & machinery: Rs. 125 Lakhs
Working capital: -T.C.I: Cost of Project: Rs. 1339 Lakhs
Return: 43.00%Break even: 54.00%
Add to Inquiry Add to Inquiry Basket

Saline and Dextrose Fluid (IV Fluid) BFS Technology

As part of the millennium development goals (MDGs), governments in the region have developed strategies directed at reducing the negative impact of diseases like HIV, Malaria or Tuberculosis on the society by 2015. The strategies include halting and reversing the spread of HIV/AIDS, reducing the level of malaria infection, and reducing prevalence and death rates associated with tuberculosis. Severe malaria results into high fever, which requires the use of Intravenous Fluids as the first line of treatment. However, due to limited local production and supply, the fluids are comparatively expensive compared to other developed world where they are affordable and readily available. In India, local monopolies and distributors that sell the fluids very costly import 98% of the IV Fluids. Faced with the current factual situation Govt. Oriented organization planned to establish Intravenous Project to locally produce and supply this very essential product to the healthcare sector as a noble contribution in improving healthcare services. The project expects to promote the common good in the Eastern Region, to reduce the current high level of deaths from 9-14% of in-patient visits in hospitals and health facilities. In medicine, saline (also saline solution) is a general phrase referring to a sterile solution of sodium chloride (NaCl, more commonly known as salt) in water, but is only sterile when it is to be placed parenterally (such as intravenously); otherwise, a saline solution is a salt water solution. The sterile solution is typically used for intravenous infusion, rinsing contact lenses, nasal irrigation, and often used to clean a new piercing. It is also a good medium to store an avulsed ("knocked out") tooth until it can be re-implanted by a dentist. Saline solutions are available in various formulations for different purposes. Salines are also used in cell biology, molecular biology, and biochemistry experiments. Uses & Applications There are four main ranges of application of highly specialized intravenous infusion solutions: • Treatment of discarded water and electrolyte metabolism, especially in severe cases. • Therapy of acid base in balances. • The volume substitution and volume replacement in surgery of accident victim suffering blood lose. • Paratrial nutrition for severally ill and post-operative patients. • Aqueous isotonic injection (5%) of dextrose is given as intravenous injections to increase the column of circulating blood in the shocks and hemorrhages and to counteract dehydration. Dextrose solution is used during post operative period when sodium extraction is reduced. • Dextrose solution with concentration of 10-15% is used as diuretic for increase in urine flow. • Dextrose solution of 5% normal salmic is used for restarting fluid volume in circulation of an emergency as in accidents. • Saline solution is used when large amount of sodium has been lost by vomiting or by gastric or intestinal duodenal aspiration or through analimucation fistuala. • Dextrose monohydrate is used as supplement to cow's milk in part of feeding. • Hypertonic dextrose solution (25-50%) is in medical treatment partly because they are believed to strengthen heart muscles. • Hypertonic solutions are used in intravenous injection to relieve intractable pressure in patient with hydrocephalus and meningitis. Market Survey Our system of medicine like Ayurveda were well established and schools and hospitals with treatises and instruction manuals were in wide use. The growth of I.V. fluid manufacturing was faster than the growth rate of drugs. I.V fluids are the solutions applied directly to the vein of a patient who suffer from the weaknesses due to the deficiency of body fluids. These IV fluids are the best alternative which can yield sudden result in the health of a patient by replenishing the body fluids. Liquid glucose and dextrose are being produced in the organized sector. Glucose is produced in solid as well as in liquid form and dextrose is in anhydrous and monohydrous form. The gap between the production and consumption of liquid glucose is removed by the import. I.V. fluid demand is normally linked to the number of hospital beds. Observations show that 18 bottles of I.V. fluids are consumed per bed per month in the country. The demand is estimated to increase at a rate of 9 to 12% per annum. The present demand level is estimated to be around 2200 lakh bottles per annum. Areas with high population density and average temperatures are major consumption areas of I.V. fluids. Demand is high Uttar Pradesh, Rajasthan, Haryana, Bihar, Madhya Pradesh and West Bengal. North India alone account for one third of the total demand in the country.
Plant capacity: 48000 Bottles/day(500 ml)Plant & machinery: 253 Lakhs
Working capital: -T.C.I: Cost of Project: 834 Lakhs
Return: 29.00%Break even: 52.00%
Add to Inquiry Add to Inquiry Basket

I.V. FLUID - Manufacturing Plant, Detailed Project Report, Profile, Business Plan, Industry Trends, Market Research, Survey, Manufacturing Process, Machinery, Raw Materials, Feasibility Study, Investment Opportunities, Cost and Revenue, Plant Economics

Intravenous fluids are fluids which are intended to be administered to a patient intravenously, directly through the circulatory system. These fluids must be sterile to protect patients from injury, and there are a number of different types available for use. Fluids are given when someone's body fluid volume falls. There are a number of things which can cause a drop in fluid volume. Vomiting and diarrhea are a classic example, which is why people are encouraged to drink fluids when they are sick, to keep their fluid volume stable. Another cause is blood loss, which causes problems both because people lose blood products, and because they experience a loss in fluid volume. Electrolyte levels in the blood can also become unstable as a result of rapid changes in fluid volume, in which case intravenous fluids can be used to restore the balance. Intravenous fluids can be broken into two broad groups. Crystalloids such as saline solutions contain a solution of molecules which can dissolve in water. When crystalloids are administered, they tend to create low osmotic pressure, allowing fluid to move across the blood vessels, and this can be linked with edema. Colloids contain particles which are not soluble in water, and they create high osmotic pressure, attracting fluid into the blood vessels. Blood is an example of a commonly administered intravenous colloid. Intravenous fluids can also be used as a route of medication administration. If a doctor wants to deliver a small amount of medication over an extended period of time, it can be dissolved in a bag of intravenous fluids and set on an infusion pump which delivers the medicated fluid directly into the blood. They are also commonly used to assist with surgical recovery; people who receive fluids after surgery tend to experience better recovery than people who do not. There are many solutions are used for IV fluids. The specific one used depends on the situation. Many other compounds can be added to the IV solution as a simple means of administration. For example, antibiotics, pain killers and so on can be added to the IV so the patient receives the drug at a constant rate over a long period of time. The basic function of IV fluids is to replenish the body fluids. Although there are a number of IV fluids but generally three types of IV fluids are used in hospitals as IV drips. They are as follows: 1. Dextrose injection fluid 2. Dextrose and sodium chloride injection fluid 3. Sodium chloride injection solution (Saline solution). When saline is injected intravenously, it compensate the deficiency of sodium ions when dextrose is injected it gives energy due to glucose content of it when dextro-saline is given in combination, it replenishes the dehydration as well as gives energy thereby recouping debility syndrome and also in general take care of malaise. Uses There are four main ranges of application of highly specialized intravenous infusion solutions: 1. Treatment of discarded water and electrolyte metabolism, especially in severe cases. 2. Therapy of acid base in balances. 3. The volume substitution and volume replacement in surgery of accident victim suffering blood loss. 4. Paratral nutrition for severally ill and post-operative patients. 5. Aqueous isotonic injection (5%) of dextrose is given as intravenous injections to increase the column of circulating blood in the shocks and haemarrhages and to counteract dehydration. When it is desired to replace excessive salt loss also glucose is injected along with sodium chloride. 6. Dextrose solution is used during postoperative period when sodium extraction is reduced. 7. Dextrose solution with concentration of 10-15% is used as diuretic for increase in urine flow. 8. Dextrose solutions of 5% normal salinic are used for restoring fluid volume in circulation of an emergency as in accidents with haemarrhage. Saline solution is used when large amount of sodium has been lost by vomiting or by gastric or intestinal duodenal aspiration or through an alimentary fistula. 9. Dextrose monohydrate is used as supplement to cow's milk in part of feeding. 10. Hypertonic dextrose solution (25-50%) is in medical treatment partly because they are believed to strengthen heart muscles. Hypertonic solutions are used in intravenous injection to relieve intractable pressure in-patient with hydrocephalus and meningitis. Market Survey India's traditions in the science of health and healing go back to the halcyon days of Surushta, Vagbhatta and Charaka. Our system of medicine like Ayurveda were well established and schools and hospitals with treatises and instruction manuals were in wide use. The establishment of modern pharmaceutical industry in India may be said to have commercial with the selling up of Bengal chemicals by acharya P.C Ray in Kolkata and of Alembic Chemical in B.D Amin. The growth of I.V. fluid manufacturing was faster than the growth rate of drugs. I.V fluids are the solutions applied directly to the vein of a patient who suffer from the weaknesses due to the deficiency of body fluids. These IV fluids are the best alternative which can yield sudden result in the health of a patient by replanishing the body fluids. Liquid glucose and dextrose are being produced in the organized sector. Glucose is produced in solid as well as in liquid form and dextrose is in anhydrous and monohydros form. The installed capacity, production and capacity utilization of liquid glucose are indicated below. I.V. fluid demand is normally linked to the number of hospital beds. Observations show that 18 bottles of I.V. fluids are consumed per bed per month in the country. The demand is estimated to increase at a rate of 9 to 12% per annum. The present demand level is estimated to be around 2200 Lakh bottles per annum. Areas with high population density and average temperatures are major consumption areas of I.V. fluids. Demand is high Uttar Pradesh, Rajasthan, Haryana, Bihar, Madhya Pradesh and West Bengal. North India alone account for one third of the total demand in the country. Few Indian Major Players are as under Ahlcon Parenterals (India) Ltd. Core Laboratories Ltd. Gujarat Ambuja Proteins Ltd. Gujarat Inject Ltd. Haffkine Bio-Pharmaceutical Corpn. Ltd. India Infusion Ltd. Indian Maize & Chemicals Ltd. K G Gluco Biols Ltd. Kamala Sugar Mills Ltd. Kokad Pharmaceutical Laboratories Ltd. Marck Biosciences Ltd. Origin Agrostar Ltd. Parenteral Surgicals Ltd. Senbo Industries Ltd. Span Medicals Ltd. Tirupati Starch & Chemicals Ltd. Unique Sugars Ltd. Wockhardt Health Care Ltd.
Plant capacity: 144,00,000 Bottles/AnnumPlant & machinery: Rs. 808 Lakhs
Working capital: -T.C.I: Cost of Project: Rs 1367 Lakhs
Return: 26.00%Break even: 46.00%
Add to Inquiry Add to Inquiry Basket

Disposable Plastic Syringes - Manufacturing Plant, Detailed Project Report, Profile, Business Plan, Industry Trends, Market Research, Survey, Manufacturing Process, Machinery, Raw Materials, Feasibility Study, Investment Opportunities, Cost and Revenue

It is an instrument which is used for injecting any liquid into the body of human beings or of animals. These syringes are used for injecting the medicine into the body or into the nerve of the body which are not possible to take in through mouth or takes much time in mixing with blood. A syringe is a simple piston pump consisting of a plunger that fits tightly in a tube. The plunger can be pulled and pushed along inside a cylindrical tube (the barrel), allowing the syringe to take in and expel a liquid or gas through an orifice at the open end of the tube. The open end of the syringe may be fitted with a hypodermic needle, a nozzle, or tubing to help direct the flow into and out of the barrel. The constantly increasing use of Disposable Syringes made of plastic Material indicates its importance, which is based mainly on the advantages it offers regarding cost and hygienic applications. Due to their availability is sterilized condition, ready to use and cost effectiveness, disposable syringes are fast replacing the age-old glass syringes. Disposable syringes are mostly injection moulded from polypropylene. Syringes are available in sizes of 1ml, 2ml, and 10ml, in a variety of designs and consist of either two or three components in their material of construction. The number and size of injection moulding machines required depends upon syringe construction, number of mould cavities and annual production. Uses & Applications Disposable syringes commonly are used in modern medicine for the injection of drugs and vaccines or for the extraction of blood. Among the common uses of disposable syringes are the injecting of insulin by a diabetic person and the administering of a local anesthesia by a dentist. Disposable syringes are favored over reusable syringes for vaccines, in order to avoid the risk of transmitting blood-borne diseases such as human immunodeficiency virus (HIV) and hepatitis from one person to another. Disposable syringes also are used to inject anesthetics for medical procedures. They can be used either alone or in combination with anesthetic gas for general anesthesia. They can be used in combination with anesthetic spray or cream for local anesthesia. The syringes used by dentists to administer local anesthesia before drilling or pulling teeth are a common example. Disposable syringes sometimes are used for drawing blood samples. They allow greater precision than evacuated tube systems, so syringes used together with butterfly needles often are favored when drawing blood. Market Survey The Indian healthcare sector, including pharmaceutical, diagnostics and hospital services, is expected to more than double its revenues to Rs 2500 bn by 2014. Expenditure on healthcare services, including diagnostics, hospital occupancy and outpatient consulting, the largest component of this spend is expected to grow more than 125% to Rs 1560 bn. The Indian domestic Medicare devices industry is expected to grow from Rs 60 bn to Rs 76.5 bn in four years. The overall market is estimated at Rs 150 bn. A major part of the demand is met through imports. Devices, such as catheters and stents represent nearly two-fifth of the entire range of diagnostic devices and most critical as per international classification. Presently medical devices are treated like drugs and regulated by state drug regulators under the drug law - Drugs and Cosmetics Act. Guidelines would make it mandatory for producers to get their products certified by notified bodies like ISO and BIS. The market for non-premium equipments, appliances and disposables is, however, dominated by the domestic manufacturers, while foreign suppliers and Indian companies with foreign alliances dominate the high-end hi-tech medical equipment and appliances. With the healthcare sector being opened up to private players, India is now emerging as a lucrative market for global firms dealing in hi-tech diagnostic and imaging equipment. In the Indian single uses syringes market, which is nearly 1.5 bn units strong, Hindustan Syringes and Medical Devices (HMD) enjoys a 65% market share. Imports constitute 10% of this market. In the single use needles market, HMD has a 70% market share, followed by imported brands with a 25% market share. The size of the local needles market is 2.5 bn units per annum. With the opening of healthcare sector, the market for medical equipment and accessories has become more vibrant. A large number of new medical facilities have been created by a large numbers of service providers, which is indicative of the great potential for medical equipment in India. The Indian market is expanding in all directions as a result of better affordability, greater health consciousness and expanding medical service institutions. With a population of 1.15 bn, India will need to at least 2 mn beds in the next 10 years in order to attain a modest target of 2 per 1000 of population. With a total healthcare value of USD 400 bn, the potential for Medicare equipment is, indeed large. Although there is a large untapped potential, the industry is confronted with problems of low volumes, high cost of production/operation, and rapid obsolescence as a result of accelerated, almost continuous, technological breakthroughs. The fragmentation of production facilities forestalls any worthwhile effort at R&D. This leads to industry's dependence on imported technology. Nonetheless, it is crystal clear that with the fast commercialization process of the sector and upgradation of medical facilities, the potential is sky-high. Few Major Players are listed below: Albert David Ltd. Disposable Medi-Aids Ltd. H L L Lifecare Ltd. Hindustan Syringes & Medical Devices Ltd. Iscon Surgicals Ltd. La Medical Devices Ltd. Lifeline Injects Ltd. Lifelong Meditech Ltd. Nirma Ltd. Raaj Medisafe India Ltd. Sangam Health Care Products Ltd. Surgiplast Ltd.
Plant capacity: 180 Lakh Nos. /annumPlant & machinery: 245 Lakhs
Working capital: -T.C.I: Cost of Project: 455 Lakhs
Return: 26.00%Break even: 46.00%
Add to Inquiry Add to Inquiry Basket

Saline and Dextrose Fluid (IV Fluid) BFS Technology

As part of the millennium development goals (MDGs), governments in the region have developed strategies directed at reducing the negative impact of diseases like HIV, Malaria or Tuberculosis on the society by 2015. The strategies include halting and reversing the spread of HIV/AIDS, reducing the level of malaria infection, and reducing prevalence and death rates associated with tuberculosis. Severe malaria results into high fever, which requires the use of Intravenous Fluids as the first line of treatment. However, due to limited local production and supply, the fluids are comparatively expensive compared to other developed world where they are affordable and readily available. In India, local monopolies and distributors that sell the fluids very costly import 98% of the IV Fluids. Faced with the current factual situation Govt. Oriented organization planned to establish Intravenous Project to locally produce and supply this very essential product to the healthcare sector as a noble contribution in improving healthcare services. The project expects to promote the common good in the Eastern Region, to reduce the current high level of deaths from 9-14% of in-patient visits in hospitals and health facilities. In medicine, saline (also saline solution) is a general phrase referring to a sterile solution of sodium chloride (NaCl, more commonly known as salt) in water, but is only sterile when it is to be placed parenterally (such as intravenously); otherwise, a saline solution is a salt water solution. The sterile solution is typically used for intravenous infusion, rinsing contact lenses, nasal irrigation, and often used to clean a new piercing. It is also a good medium to store an avulsed ("knocked out") tooth until it can be re-implanted by a dentist. Saline solutions are available in various formulations for different purposes. Salines are also used in cell biology, molecular biology, and biochemistry experiments. Uses & Applications There are four main ranges of application of highly specialized intravenous infusion solutions: • Treatment of discarded water and electrolyte metabolism, especially in severe cases. • Therapy of acid base in balances. • The volume substitution and volume replacement in surgery of accident victim suffering blood lose. • Paratrial nutrition for severally ill and post-operative patients. • Aqueous isotonic injection (5%) of dextrose is given as intravenous injections to increase the column of circulating blood in the shocks and hemorrhages and to counteract dehydration. Dextrose solution is used during post operative period when sodium extraction is reduced. • Dextrose solution with concentration of 10-15% is used as diuretic for increase in urine flow. • Dextrose solution of 5% normal salmic is used for restarting fluid volume in circulation of an emergency as in accidents. • Saline solution is used when large amount of sodium has been lost by vomiting or by gastric or intestinal duodenal aspiration or through analimucation fistuala. • Dextrose monohydrate is used as supplement to cow's milk in part of feeding. • Hypertonic dextrose solution (25-50%) is in medical treatment partly because they are believed to strengthen heart muscles. • Hypertonic solutions are used in intravenous injection to relieve intractable pressure in patient with hydrocephalus and meningitis. Market Survey Our system of medicine like Ayurveda were well established and schools and hospitals with treatises and instruction manuals were in wide use. The growth of I.V. fluid manufacturing was faster than the growth rate of drugs. I.V fluids are the solutions applied directly to the vein of a patient who suffer from the weaknesses due to the deficiency of body fluids. These IV fluids are the best alternative which can yield sudden result in the health of a patient by replenishing the body fluids. Liquid glucose and dextrose are being produced in the organized sector. Glucose is produced in solid as well as in liquid form and dextrose is in anhydrous and monohydrous form. The gap between the production and consumption of liquid glucose is removed by the import. I.V. fluid demand is normally linked to the number of hospital beds. Observations show that 18 bottles of I.V. fluids are consumed per bed per month in the country. The demand is estimated to increase at a rate of 9 to 12% per annum. The present demand level is estimated to be around 2200 lakh bottles per annum. Areas with high population density and average temperatures are major consumption areas of I.V. fluids. Demand is high Uttar Pradesh, Rajasthan, Haryana, Bihar, Madhya Pradesh and West Bengal. North India alone account for one third of the total demand in the country.
Plant capacity: 48000 Bottles/day(500 ml)Plant & machinery: 253 Lakhs
Working capital: -T.C.I: Cost of Project: 834 Lakhs
Return: 29.00%Break even: 52.00%
Add to Inquiry Add to Inquiry Basket

I.V. Fluid - Manufacturing Plant, Detailed Project Report, Profile, Business Plan, Industry Trends, Market Research, Survey, Manufacturing Process, Machinery, Raw Materials, Feasibility Study, Investment Opportunities, Cost and Revenue, Plant Economics

Intravenous fluids are fluids which are intended to be administered to a patient intravenously, directly through the circulatory system. Fluids are given when someone's body fluid volume falls. Liquid glucose and dextrose are being produced in the organized sector. I.V. fluid demand is normally linked to the number of hospital beds. Observations show that 18 bottles of I.V. fluids are consumed per bed per month in the country. The demand is estimated to increase at a rate of 9 to 12% per annum. The present demand level is estimated to be around 2200 Lakh bottles per annum. Areas with high population density and average temperatures are major consumption areas of I.V. fluids. Demand is high Uttar Pradesh, Rajasthan, Haryana, Bihar, Madhya Pradesh and West Bengal. North India alone account for one third of the total demand in the country. Few Indian Major Players are as under Ahlcon Parenterals (India) Ltd. Core Laboratories Ltd. Gujarat Ambuja Proteins Ltd. Gujarat Inject Ltd. Haffkine Bio-Pharmaceutical Corpn. Ltd. India Infusion Ltd. Indian Maize & Chemicals Ltd. K G Gluco Biols Ltd. Kamala Sugar Mills Ltd. Kokad Pharmaceutical Laboratories Ltd. Marck Biosciences Ltd. Origin Agrostar Ltd. Parenteral Surgicals Ltd. Senbo Industries Ltd. Span Medicals Ltd. Tirupati Starch & Chemicals Ltd. Unique Sugars Ltd. Wockhardt Health Care Ltd.
Plant capacity: 144,00,000 Bottles/AnnumPlant & machinery: Rs. 808 Lakhs
Working capital: -T.C.I: Cost of Project: Rs 1367 Lakhs
Return: 26.00%Break even: 46.00%
Add to Inquiry Add to Inquiry Basket

Disposable Plastic Syringes - Manufacturing Plant, Detailed Project Report, Profile, Business Plan, Industry Trends, Market Research, Survey, Manufacturing Process, Machinery, Raw Materials, Feasibility Study, Investment Opportunities, Cost and Revenue

It is an instrument which is used for injecting any liquid into the body of human beings or of animals. The Indian healthcare sector, including pharmaceutical, diagnostics and hospital services, is expected to more than double its revenues to Rs 2500 bn by 2014. The Indian domestic Medicare devices industry is expected to grow from Rs 60 bn to Rs 76.5 bn in four years. The overall market is estimated at Rs 150 bn. A major part of the demand is met through imports. With the healthcare sector being opened up to private players, India is now emerging as a lucrative market for global firms dealing in hi-tech diagnostic and imaging equipment. In the Indian single uses syringes market, which is nearly 1.5 bn units strong, Hindustan Syringes and Medical Devices (HMD) enjoys a 65% market share. Imports constitute 10% of this market. In the single use needles market, HMD has a 70% market share, followed by imported brands with a 25% market share. The size of the local needles market is 2.5 bn units per annum. It is crystal clear that with the fast commercialization process of the sector and upgradation of medical facilities, the potential is sky-high. Few Major Players are listed below: Albert David Ltd. Disposable Medi-Aids Ltd. H L L Lifecare Ltd. Hindustan Syringes & Medical Devices Ltd. Iscon Surgicals Ltd. La Medical Devices Ltd. Lifeline Injects Ltd. Lifelong Meditech Ltd. Nirma Ltd. Raaj Medisafe India Ltd. Sangam Health Care Products Ltd. Surgiplast Ltd.
Plant capacity: 180 Lakh Nos. /annumPlant & machinery: Rs.245 Lakhs
Working capital: -T.C.I: Cost of Project:Rs. 455 Lakhs
Return: 26.00%Break even: 46.00%
Add to Inquiry Add to Inquiry Basket

Saline and Dextrose Fluid (IV) - Manufacturing Plant, Detailed Project Report, Profile, Business Plan, Industry Trends, Market Research, Survey, Manufacturing Process, Machinery, Raw Materials, Feasibility Study, Investment Opportunities, Cost and Revenue

The growth of I.V. fluid manufacturing was faster than the growth rate of drugs. These IV fluids are the best alternative which can yield sudden result in the health of a patient by replenishing the body fluids. Liquid glucose and dextrose are being produced in the organized sector. The gap between the production and consumption of liquid glucose is removed by the import. I.V. fluid demand is normally linked to the number of hospital beds. Observations show that 18 bottles of I.V. fluids are consumed per bed per month in the country. The demand is estimated to increase at a rate of 9 to 12% per annum. The present demand level is estimated to be around 2200 lakh bottles per annum. Demand is high Uttar Pradesh, Rajasthan, Haryana, Bihar, Madhya Pradesh and West Bengal. North India alone account for one third of the total demand in the country.
Plant capacity: -Plant & machinery: -
Working capital: -T.C.I: -
Return: 1.00%Break even: 1.00%
Add to Inquiry Add to Inquiry Basket

Surgical Gloves - Manufacturing Plant, Detailed Project Report, Profile, Business Plan, Industry Trends, Market Research, Survey, Manufacturing Process, Machinery, Raw Materials, Feasibility Study, Investment Opportunities, Cost and Revenue, Plant Layout

The powder-free and synthetic disposable latex gloves market is anticipated to thrive in the next three to five years due to increased healthcare spending and greater number of people being covered by insurance. The global market for disposable medical gloves generated $3 billion revenues in 2011. Marketstrat forecasts that this market will continue to expand at a compound annual growth of 4.9% exceeding $4.3 billion by 2018. Key market and technology drivers include concern over barrier protection, ease of use, tactility and comfort. This is the new emerging field and has a good domestic and international market. New entrepreneurs can well venture in this sector. Few Major Players are named as under: Bengal Waterproof Ltd. C E Gloves (India) Ltd. Casil Health Products Ltd. Casil Industries Ltd. Digiflex (India) Ltd. J K Ansell Ltd. London Rubber India Ltd. Mega Meditex Ltd. Sataytej Commercial Co. Ltd. Shiva Medicare Ltd. T T K Biomed Ltd.
Plant capacity: 6000000 Pairs/AnnumPlant & machinery: Rs.154 Lakhs
Working capital: -T.C.I: Cost of Project: Rs.323 Lakhs
Return: 23.00%Break even: 48.00%
Add to Inquiry Add to Inquiry Basket

Pharmaceutical Unit(Automatic Plant of Tablet and Capsule) - Manufacturing Plant, Detailed Project Report, Profile, Business Plan, Industry Trends, Market Research, Survey, Manufacturing Process, Machinery, Raw Materials, Feasibility Study

The Indian Pharmaceutical sector is highly fragmented with more than 20,000 registered units. It has expanded drastically in the last two decades. The leading 250 pharmaceutical companies control 70% of the market, with market leader holding nearly 7% of the market share. There are about 250 large units and about 8000 Small Scale Units, which form the core of the pharmaceutical industry in India (including 5 Central Public Sector Units). These units produce the complete range of pharmaceutical formulations, i.e., medicines ready for consumption by patients and about 350 bulk drugs etc. Technologically strong and totally self-reliant, the pharmaceutical industry in India has low costs of production, low R&D costs, innovative scientific manpower, strength of national laboratories and an increasing balance of trade. The Indian pharmaceutical industry is the fourth largest in the world in terms of volume of output and thirteenth in domestic demand. The domestic market is estimated at Rs 680 bn. The key categories driving growth are the traditionally largest segment - anti-infective and gastro-intestinal, drugs, which expanded by 22% and 19% respectively. Fast sales growth is also visible in categories like respiratory (18%), cardiac (14%), neurology (20%) and anti-diabetic (19%). The number of product launches exceeds 2,000 annually. Both MNC and Indian companies are implementing strategies which will help them to benefit from and cope with the developing patent regime. India has the highest number of (US Food and Drug Administration) USFDA approved manufacturing facilities outside the US and this puts India in good position to export to regulated markets. The major players in the country are: Aanjaneya Lifecare Ltd. Aashi Industries Ltd. Abbott India Ltd. Advik Laboratories Ltd. Aesculapius Remedies Ltd. Ajanta Pharma Ltd. Albert David Ltd. Alkem Laboratories Ltd. Alpa Laboratories Ltd. Ambalal Sarabhai Enterprises Ltd. Amee Cosmo Pharma Ltd. American Remedies Ltd. Amstrin Healthcare Ltd. Anan Drug & Chem Ltd. Andre Laboratories Ltd. Anglo-French Drugs & Inds. Ltd. Ankur Drugs & Pharma Ltd. Anmol Drugs & Pharmaceuticals Ltd. Anuh Pharma Ltd. Apex Laboratories Ltd. Apple Laboratories Ltd. Armour Chemicals Ltd. Arvind Remedies Ltd. Astrazeneca Pharma India Ltd. Astron Drugs & Inds. Ltd. Aurobindo Pharma Ltd. Aventis Pharma Ltd. B D H Industries Ltd. Bafna Pharmaceuticals Ltd. Bal Pharma Ltd. Basav Chem Ltd. Bassein Drugs Ltd. Beem Healthcare Ltd. Bengal Immunity Ltd. Beryl Drugs Ltd. Bharat Parenterals Ltd. Bharat Serums & Vaccines Ltd. Biddle Sawyer Ltd. Bio-Ethicals Pharma Ltd. Biocon Biopharmaceuticals Pvt. Ltd. Biocon Ltd. Biofil Chemicals & Pharmaceuticals Ltd. Biological E. Ltd. Blue Cross Laboratories Ltd. Boehringer Mannheim India Ltd. Brabourne Enterprises Ltd. Bravo Healthcare Ltd. Brawn Biotech Ltd. Burroughs Wellcome (India) Ltd. Cadila Healthcare Ltd. Cadila Laboratories Pvt. Ltd. Cadila Pharmaceuticals Ltd. Caplin Point Laboratories Ltd. Caryl Laboratories Ltd. Casil Industries Ltd. Celestial Biolabs Ltd. Centaur Pharmaceuticals Pvt. Ltd. Cepham Organics Ltd. Cepham Pharmaceuticals Ltd. Chemech Laboratories Ltd. Chemosyn Ltd. Ciba Ckd Biochem Ltd. Claris Lifesciences Ltd. Colinz Laboratories Ltd. Combat Drugs Ltd. Concept Pharmaceuticals Ltd. Concord Biotech Ltd. Concord Drugs Ltd. Coral Laboratories Ltd. Core Laboratories Ltd. Cosme Farma Laboratories Ltd. Cosme Pharma Ltd. Creative Health Care Pvt. Ltd. Croslands Research Laboratories Ltd. Croydon Chemical Works Ltd. Curewell (India) Ltd. Damania Pharma Ltd. Deepharma Laboratories Ltd. Deepharma Ltd. Dey'S Medical Stores Mfg. Ltd. Dishman Pharmaceuticals & Chemicals Ltd. Dolphin Laboratories Ltd. Dr. Reddy'S Laboratories Ltd. Druid Pharma Ltd. Dujohn Laboratories Ltd. Dumex Ltd. Eaco Labs Ltd. Earnest Healthcare Ltd. East India Pharmaceutical Works Ltd. Ebers Pharmaceuticals Ltd. Elder Health Care Ltd. Elder Pharmaceuticals Ltd. Elder Projects Ltd. Elvina Pharmaceuticals Ltd. Emaai Pharma Ltd. Emcure Pharmaceuticals Ltd. Endo Labs Ltd. Entod Pharmaceuticals Ltd. Esskay Pharmaceuticals Ltd. Ethnor Ltd. Eupharma Laboratories Ltd. Everest Organics Ltd. Evid & Co. Chemicals Ltd. F D C Ltd. Fine Drugs & Chemicals Ltd. Flamingo Pharmaceuticals Ltd. Fredun Pharmaceuticals Ltd. Fresenius Kabi Oncology Ltd. Fulford (India) Ltd. Geno Pharmaceuticals Ltd. Gentech Laboratories Ltd. Geoffrey Manners & Co. Ltd. German Remedies Ltd. Glaxosmithkline Pharmaceuticals Ltd. Glen mark Exports Ltd. Glen mark Generics Ltd. Glen mark Laboratories Ltd. Glen mark Pharmaceuticals Ltd. Global Remedies Ltd. Goa Antibiotics & Pharmaceuticals Ltd. Group Pharmaceuticals Ltd. Guardian Health Care Ltd. Gufic Biosciences Ltd. Gujarat Inject Ltd. Gujarat Terce Laboratories Ltd. Gujarat Themis Biosyn Ltd. H O D Laboratories Ltd. Hab Pharmaceuticals & Research Ltd. Haffkine Ajintha Pharmaceuticals Ltd. Hallmark Healthcare Ltd. Harleystreet Pharmaceuticals Ltd. Health Care Ltd. Hexone Pharmaceuticals Ltd. Hindustan Max-Gb Ltd. Hub Pharmaceuticals Pvt. Ltd. I D P L (Tamil Nadu) Ltd. Icon Biopharma & Healthcare Ltd. Icpa Health Products Ltd. Idma Laboratories Ltd. Ind-Swift Laboratories Ltd. Ind-Swift Ltd. India Infusion Ltd. Indian Drugs & Pharmaceuticals Ltd. Indoco Healthcare Ltd. Indoco Remedies Ltd. Indon Healthcare Ltd. Innotech Pharma Ltd. Intas Pharmaceuticals Ltd. Intercare Limited Intercare Ltd. International Drug Co. Ltd. Inventia Healthcare Pvt. Ltd. Inwinex Pharmaceuticals Ltd. Ipca Laboratories Ltd. Ivee Injectaa Ltd. J B Chemicals & Pharmaceuticals Ltd. J K Pharmachem Ltd. Jagsonpal Exports India Pvt. Ltd. Jagsonpal Pharmaceuticals Ltd. Jenburkt Pharmaceuticals Ltd. Jilichem Laboratories (India) Ltd. John Wyeth (India) Ltd. Johnson & Johnson Ltd. Kabra Drugs Ltd. Kappac Pharma Ltd. Karnataka Antibiotics & Pharmaceuticals Ltd. Kee Pharma Ltd. Kilitch Drugs (India) Ltd. Konkan Capsules Ltd. Krebs Biochemicals & Inds. Ltd. Labinduss Ltd. Lekar Healthcare Ltd. Lekar Pharma Ltd. Lincoln Pharmaceuticals Ltd. Liva Healthcare Ltd. Lordvin Labs Ltd. Lupin Laboratories Ltd. Lupin Ltd. Lyka B D R International Ltd. Lyka Labs Ltd. Lympha Laboratories Ltd. M J Pharmaceuticals Ltd. Macleods Pharmaceuticals Ltd. Maharashtra Antibiotics & Pharmaceuticals Ltd. Makers Laboratories Ltd. Maneesh Pharmaceuticals Ltd. Manipur State Drugs & Pharmaceuticals Ltd. Marck Biosciences Ltd. Mars Life Sciences Ltd. Martin & Harris Laboratories Ltd. Max India Ltd. Mayank & Lili Pharma Ltd. Mayo (India) Ltd. Mcneil & Argus Pharmaceuticals Ltd. Medicamen Biotech Ltd. Medispan Ltd. Medley Pharmaceuticals Ltd. Meghdoot Chemicals Ltd. Meher Pharma (India) Ltd. Merck Ltd. Mercury Laboratories Ltd. Mercury Phytochem Ltd. Merind Ltd. Mesco Pharmaceuticals Ltd. Metropolitan Overseas Ltd. Micro Labs Ltd. Monarch Laboratories Ltd. Morepen Laboratories Ltd. Mount Mettur Pharmaceuticals Ltd. N B Z Pharma Ltd. N R Jet Enterprises Ltd. Natco Pharma Ltd. Nem Organics Ltd. Neon Laboratories Ltd. Nestor Pharmaceuticals Ltd. Neulife Laboratories Ltd. Nirma Ltd. Nitya Laboratories Ltd. Novartis India Ltd. Novus Pharmaceuticals Ltd. Om Pharmaceuticals Ltd. Omega Biotech Ltd. Omega Laboratories Ltd. Onco Therapies Ltd. Opec Innovations Ltd. Orchid Chemicals & Pharmaceuticals Ltd. Organon (India) Ltd. Ozone Pharmaceuticals Ltd. P C I Chemicals & Pharmaceuticals Ltd. Paam Pharmaceuticals (Delhi) Ltd. Panacea Biotec Ltd. Parabolic Drugs Ltd. Paras Pharmaceuticals Ltd. Parke-Davis (India) Ltd. Penam Laboratories Ltd. Perk Pharmaceuticals Ltd. Pfimex Pharmaceuticals Ltd. Pfizer Ltd. Phaarmasia Ltd. Phar-East Laboratories Ltd. Pharmacia Healthcare Ltd. Pharmaids Pharmaceuticals Ltd. Pharmax Corporation Ltd. Pharmed Ltd. Phyto Specialities Pvt. Ltd. Plethico Pharmaceuticals Ltd. Procter & Gamble Hygiene & Health Care Ltd. Quality Pharmaceuticals Ltd. R P G Life Sciences Ltd. Rajasthan Drugs & Pharmaceuticals Ltd. Rajat Pharmachem Ltd. Ranbaxy Drugs Ltd. Ranbaxy Laboratories Ltd. Raptakos, Brett & Co. Ltd. Ravish Infusions Ltd. Reckitt Benckiser (India) Ltd. Rekvina Laboratories Ltd. Resonance Specialties Ltd. Rhone-Poulenc (India) Ltd. Rolex Pharmaceuticals Ltd. Rosemount Pharma India Ltd. Rubra Medicaments Ltd. Rupal Chemical Inds. Ltd. Rusan Pharma Ltd. S A M Biotech Ltd. Saket Projects Ltd. Sandoz (India) Ltd. [Amalgamated] Sanjeevanee Pharmaceuticals Ltd. Sanjivani Paranteral Ltd. Sanofi-Synthelabo (India) Ltd. Sarabhai Piramal Pharmaceuticals Pvt. Ltd. Sarala Pharmaceuticals Ltd. Sarthi Pharmaceuticals Ltd. Sarvodaya Labs Ltd. Schering-Plough (India) Pvt. Ltd. Senbo Industries Ltd. Shalina Laboratories Pvt. Ltd. Sharvani Pharmaceuticals Ltd. Shiv Herbal Research Laboratory Ltd. Sidmak Laboratories (India) Pvt. Ltd. Sigma Laboratories Ltd. Smith Stanistreet Pharmaceuticals Ltd. Smithkline Beecham Pharmaceuticals (India) Ltd. [Amalgamated] Solumiks Herbaceuticals Ltd. Sri Chakra Remedies Ltd. Sri Krishna Drugs Ltd. Sri Krishna Pharmaceuticals Ltd. Strides Arcolab Ltd. Sun Pharmaceutical Inds. Ltd. Surya Pharmaceutical Ltd. Sustime Pharma Ltd. Suyog Pharmaceuticals Pvt. Ltd. Swega Laboratories Ltd. Swet-Chem Antibiotics Ltd. Syncom Formulations (India) Ltd. Syncom Healthcare Ltd. T K Healthcare Ltd. Tablets (India) Ltd. Tamilnadu Dadha Pharmaceuticals Ltd. Targof Pure Drugs Ltd. Taulis Pharma Ltd. Teem Laboratories Ltd. Themis Medicare Ltd. Tonira Pharma Ltd. Torrent Pharmaceuticals Ltd. Toshvin Industries Ltd. Trans Medicare Ltd. Travel Co. In Pvt. Ltd. Troika Pharmaceuticals Ltd. Twilight Litaka Pharma Ltd. U S V Ltd. Uni-Sankyo Ltd. Uni-Ucb Ltd. Unibios Laboratories Ltd. Unichem Laboratories Ltd. Unicorn Pharmaceuticals (India) Ltd. Unimark Remedies Ltd. Unimed Investments Ltd. Unimed Technologies Ltd. Unique Pharmaceutical Laboratories Ltd. Universal Generics Ltd. Universal Pharmaceuticals Ltd. Unjha Formulations Ltd. Vellanova Pharmaceuticals Ltd. Venkat Pharma Ltd. Veronica Laboratories Ltd. Vista Pharmaceuticals Ltd. Vita Biopharma Pvt. Ltd. Vysali Pharmaceuticals Ltd. Wallace Pharmaceuticals Ltd. Wander Pvt. Ltd. Warren Pharmaceuticals Ltd. Welcure Drugs & Pharmaceuticals Ltd. White Way Products (Pharma) Ltd. Win-Medicare Pvt. Ltd. Wintac Ltd. Wockhardt’s Ltd. Wyeth Laboratories Ltd. Wyeth Ltd. Yogi Healthcare Ltd. Zenith Health Care Ltd. Zenotech Laboratories Ltd. Zillion Pharmachem Ltd. Zim Laboratories Ltd. Zuventus Healthcare Ltd. Zydus Animal Health Ltd. Zydus Pathline Ltd.
Plant capacity: 117 Lakhs Nos. /annumPlant & machinery: Rs. 125 Lakhs
Working capital: -T.C.I: Cost of Project: Rs. 1340 Lakhs
Return: 43.47%Break even: 54.86%
Add to Inquiry Add to Inquiry Basket

Information
  • One Lac / Lakh / Lakhs is equivalent to one hundred thousand (100,000)
  • One Crore is equivalent to ten million (10,000,000)
  • T.C.I is Total Capital Investment
  • We can modify the project capacity and project cost as per your requirement.
  • We can also prepare project report on any subject as per your requirement.
  • Caution: The project's cost, capacity and return are subject to change without any notice. Future projects may have different values of project cost, capacity or return.

Add multiple items to inquiry
Select the items and then press Add to inquiry button

Page 12 of 21 | Total 203 projects in this category
« Previous   Page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 .... 20 21   Next »

About NIIR PROJECT CONSULTANCY SERVICES

Hide »

NIIR PROJECT CONSULTANCY SERVICES (NPCS) is a reliable name in the industrial world for offering integrated technical consultancy services. NPCS is manned by engineers, planners, specialists, financial experts, economic analysts and design specialists with extensive experience in the related industries.

Our various services are: Detailed Project Report, Business Plan for Manufacturing Plant, Start-up Ideas, Business Ideas for Entrepreneurs, Start up Business Opportunities, entrepreneurship projects, Successful Business Plan, Industry Trends, Market Research, Manufacturing Process, Machinery, Raw Materials, project report, Cost and Revenue, Pre-feasibility study for Profitable Manufacturing Business, Project Identification, Project Feasibility and Market Study, Identification of Profitable Industrial Project Opportunities, Business Opportunities, Investment Opportunities for Most Profitable Business in India, Manufacturing Business Ideas, Preparation of Project Profile, Pre-Investment and Pre-Feasibility Study, Market Research Study, Preparation of Techno-Economic Feasibility Report, Identification and Selection of Plant, Process, Equipment, General Guidance, Startup Help, Technical and Commercial Counseling for setting up new industrial project and Most Profitable Small Scale Business.

NPCS also publishes varies process technology, technical, reference, self employment and startup books, directory, business and industry database, bankable detailed project report, market research report on various industries, small scale industry and profit making business. Besides being used by manufacturers, industrialists and entrepreneurs, our publications are also used by professionals including project engineers, information services bureau, consultants and project consultancy firms as one of the input in their research.

^ Top